These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16736695)

  • 1. [HeartScore: new "national" computer program for prevention. The German risk was overestimated until now].
    Aumiller J
    MMW Fortschr Med; 2006 May; 148(19):8. PubMed ID: 16736695
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular prevention: new study, new guidelines. The effort keeping the heart healthy].
    Einecke D
    MMW Fortschr Med; 2004 Sep; 146(38):4-6, 8. PubMed ID: 15532422
    [No Abstract]   [Full Text] [Related]  

  • 3. [HeartScore, PC-based cardiovascular risk assessment. A cooperation between general practitioners and cardiologists].
    Perk J; Thomsen T
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1893-5. PubMed ID: 16044769
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Social medicine and epidemiology: significance for conquering illness].
    Löwel H
    Gesundheitswesen; 1996 Oct; 58 Suppl 3():174-9. PubMed ID: 9156615
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of total cardiovascular risk assessment in clinical practice.
    Graham IM
    Eur J Gen Pract; 2006; 12(4):148-55. PubMed ID: 17127600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The 2005 BayRad Initiative. Cardiovascular prevention--more necessary than ever].
    Rothe HJ
    Krankenpfl J; 2005; 43(4-6):111. PubMed ID: 16171057
    [No Abstract]   [Full Text] [Related]  

  • 8. How to improve cardiovascular diseases prevention in Europe?
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):451-4. PubMed ID: 19631516
    [No Abstract]   [Full Text] [Related]  

  • 9. Global preventive policies. Strategies at European and worldwide level.
    Kotseva K
    Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polish forum for prevention guidelines on cardiovascular risk assessment].
    Podolec P; Kopeć G; Pajak A; Undas A; Kozek E; Tykarski A; Naruszewicz M; Stańczyk J; Opala G; Godycki-Cwirko M; Rynkiewicz A; Torbicki A; Musiał J
    Kardiol Pol; 2007 Jan; 65(1):100-4. PubMed ID: 17295170
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of coronary heart disease and the National Cholesterol Education Program.
    Kuller LH
    Circulation; 2006 Feb; 113(5):598-600. PubMed ID: 16461829
    [No Abstract]   [Full Text] [Related]  

  • 12. Stair use for cardiovascular disease prevention.
    Meyer P; Kayser B; Mach F
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S17-8. PubMed ID: 19675430
    [No Abstract]   [Full Text] [Related]  

  • 13. Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases.
    Undas A; Podolec P; Kopeć G; Pajak A; Gasior Z; Małecki M; Pasowicz M; Rynkiewicz A; Torbicki A; Zdrojeski T; Czarnecka D; Drygas W; Godycki-Cwirko M; Kozek E; Naruszewicz M; Opala G; Stańczyk J; Sieradzki J
    Kardiol Pol; 2007 Nov; 65(11):1396-8. PubMed ID: 18303602
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
    Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL;
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of adiposity and inactivity in primary prevention of cardiovascular disease].
    König D; Bönner G; Berg A
    Herz; 2007 Oct; 32(7):553-9. PubMed ID: 17972028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The high risk patient (case report)].
    Biermann J; Herrmann W
    Z Arztl Fortbild (Jena); 1991 Jun; 85(11):511-2. PubMed ID: 1897269
    [No Abstract]   [Full Text] [Related]  

  • 17. [Position paper on primary prevention of cardiovascular diseases. Current edition of 25 March 2003 by the governing body of the German Society of Cardiology-Heart- and Cardiovascular Research, revised by request of the governing body via the Prevention Project Group].
    Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G
    Z Kardiol; 2004; 93 Suppl 2():II43-5. PubMed ID: 15021996
    [No Abstract]   [Full Text] [Related]  

  • 18. The predictive value of cardiorespiratory fitness combined with coronary risk evaluation and the risk of cardiovascular and all-cause death.
    Laukkanen JA; Rauramaa R; Salonen JT; Kurl S
    J Intern Med; 2007 Aug; 262(2):263-72. PubMed ID: 17645594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise workload, coronary risk evaluation and the risk of cardiovascular and all-cause death in middle-aged men.
    Laukkanen JA; Rauramaa R; Kurl S
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):285-92. PubMed ID: 18525382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.